---
layout: default
title: EXAONE Path 2.5: Pathology Foundation Model with Multi-Omics Alignment
---

# EXAONE Path 2.5: Pathology Foundation Model with Multi-Omics Alignment

**arXiv**: [2512.14019v1](https://arxiv.org/abs/2512.14019) | [PDF](https://arxiv.org/pdf/2512.14019.pdf)

**ä½œè€…**: Juseung Yun, Sunwoo Yu, Sumin Ha, Jonghyun Kim, Janghyeon Lee, Jongseong Jang, Soonyoung Lee

**åˆ†ç±»**: cs.LG, q-bio.QM

**å‘å¸ƒæ—¥æœŸ**: 2025-12-16

---

## ðŸ’¡ ä¸€å¥è¯è¦ç‚¹

**EXAONE Path 2.5ï¼šå¤šç»„å­¦å¯¹é½çš„ç—…ç†å­¦åŸºç¡€æ¨¡åž‹ï¼Œç”¨äºŽæ›´å…¨é¢çš„è‚¿ç˜¤ç”Ÿç‰©å­¦ç†è§£ã€‚**

ðŸŽ¯ **åŒ¹é…é¢†åŸŸ**: **å…·èº«æ™ºèƒ½ä¸Žè¡¨å¾å­¦ä¹  (Embodied AI & Representation)**

**å…³é”®è¯**: `ç—…ç†å­¦` `å¤šç»„å­¦` `åŸºç¡€æ¨¡åž‹` `å¯¹æ¯”å­¦ä¹ ` `ç²¾å‡†è‚¿ç˜¤å­¦`

## ðŸ“‹ æ ¸å¿ƒè¦ç‚¹

1. çŽ°æœ‰ç—…ç†å­¦æ¨¡åž‹ä¸»è¦ä¾èµ–å›¾åƒä¿¡æ¯ï¼Œå¿½ç•¥äº†åŸºå› ç»„å­¦ç­‰å¤šç»„å­¦æ•°æ®ï¼Œé™åˆ¶äº†å¯¹è‚¿ç˜¤ç”Ÿç‰©å­¦çš„å…¨é¢ç†è§£ã€‚
2. EXAONE Path 2.5é€šè¿‡å¤šæ¨¡æ€SigLIPæŸå¤±ã€F-RoPEæ¨¡å—å’Œé¢†åŸŸä¸“ç”¨åŸºç¡€æ¨¡åž‹ï¼Œå®žçŽ°äº†ç»„ç»‡å­¦ã€åŸºå› ç»„å­¦ç­‰å¤šç»„å­¦ä¿¡æ¯çš„è”åˆå»ºæ¨¡ã€‚
3. å®žéªŒè¡¨æ˜Žï¼ŒEXAONE Path 2.5åœ¨Patho-Benchä¸Šè¾¾åˆ°SOTAæ€§èƒ½ï¼Œå¹¶åœ¨å†…éƒ¨ä¸´åºŠæ•°æ®é›†ä¸­è¡¨çŽ°å‡ºæ›´å¼ºçš„é€‚åº”æ€§ã€‚

## ðŸ“ æ‘˜è¦ï¼ˆä¸­æ–‡ï¼‰

ç™Œç—‡çš„è¿›å±•æºäºŽå¤šä¸ªç”Ÿç‰©å±‚é¢çš„ç›¸äº’ä½œç”¨ï¼Œç‰¹åˆ«æ˜¯å½¢æ€å­¦ä¹‹å¤–ä»¥åŠå›¾åƒæ¨¡åž‹æ— æ³•æ•æ‰çš„åˆ†å­å±‚é¢ã€‚ä¸ºäº†æ•æ‰æ›´å¹¿æ³›çš„ç”Ÿç‰©å­¦å›¾æ™¯ï¼Œæˆ‘ä»¬æå‡ºäº†EXAONE Path 2.5ï¼Œä¸€ä¸ªç—…ç†å­¦åŸºç¡€æ¨¡åž‹ï¼Œå®ƒè”åˆå»ºæ¨¡ç»„ç»‡å­¦ã€åŸºå› ç»„å­¦ã€è¡¨è§‚åŸºå› ç»„å­¦å’Œè½¬å½•ç»„å­¦æ¨¡æ€ï¼Œäº§ç”Ÿä¸€ä¸ªç»¼åˆçš„æ‚£è€…è¡¨å¾ï¼Œæ›´å…¨é¢åœ°åæ˜ è‚¿ç˜¤ç”Ÿç‰©å­¦ã€‚æˆ‘ä»¬çš„æ–¹æ³•åŒ…å«ä¸‰ä¸ªå…³é”®ç»„æˆéƒ¨åˆ†ï¼šï¼ˆ1ï¼‰å¤šæ¨¡æ€SigLIPæŸå¤±ï¼Œæ”¯æŒè·¨å¼‚æž„æ¨¡æ€çš„æ‰€æœ‰æˆå¯¹å¯¹æ¯”å­¦ä¹ ï¼›ï¼ˆ2ï¼‰ç‰‡æ®µæ„ŸçŸ¥æ—‹è½¬ä½ç½®ç¼–ç ï¼ˆF-RoPEï¼‰æ¨¡å—ï¼Œåœ¨WSIä¸­ä¿ç•™ç©ºé—´ç»“æž„å’Œç»„ç»‡ç‰‡æ®µæ‹“æ‰‘ï¼›ï¼ˆ3ï¼‰é’ˆå¯¹WSIå’ŒRNA-seqçš„é¢†åŸŸä¸“ç”¨å†…éƒ¨åŸºç¡€æ¨¡åž‹ï¼Œä¸ºç¨³å¥çš„å¤šæ¨¡æ€å¯¹é½æä¾›ç”Ÿç‰©å­¦åŸºç¡€çš„åµŒå…¥ã€‚æˆ‘ä»¬åœ¨ä¸¤ä¸ªäº’è¡¥çš„åŸºå‡†ä¸Šè¯„ä¼°äº†EXAONE Path 2.5ï¼Œä¸€ä¸ªæ˜¯å†…éƒ¨çœŸå®žä¸´åºŠæ•°æ®é›†ï¼Œå¦ä¸€ä¸ªæ˜¯æ¶µç›–80ä¸ªä»»åŠ¡çš„Patho-BenchåŸºå‡†ï¼Œå¹¶ä¸Žå…­ä¸ªé¢†å…ˆçš„ç—…ç†å­¦åŸºç¡€æ¨¡åž‹è¿›è¡Œäº†æ¯”è¾ƒã€‚æˆ‘ä»¬çš„æ¡†æž¶å±•ç¤ºäº†é«˜æ•°æ®å’Œå‚æ•°æ•ˆçŽ‡ï¼Œåœ¨Patho-Benchä¸Šå®žçŽ°äº†ä¸Žæœ€å…ˆè¿›çš„åŸºç¡€æ¨¡åž‹ç›¸å½“çš„æ€§èƒ½ï¼ŒåŒæ—¶åœ¨å†…éƒ¨ä¸´åºŠçŽ¯å¢ƒä¸­è¡¨çŽ°å‡ºæœ€é«˜çš„é€‚åº”æ€§ã€‚è¿™äº›ç»“æžœçªå‡ºäº†ç”Ÿç‰©ä¿¡æ¯å¤šæ¨¡æ€è®¾è®¡çš„ä»·å€¼ï¼Œå¹¶å¼ºè°ƒäº†ç”¨äºŽä¸‹ä¸€ä»£ç²¾å‡†è‚¿ç˜¤å­¦çš„æ•´åˆåŸºå› åž‹åˆ°è¡¨åž‹å»ºæ¨¡çš„æ½œåŠ›ã€‚

## ðŸ”¬ æ–¹æ³•è¯¦è§£

**é—®é¢˜å®šä¹‰**ï¼šçŽ°æœ‰ç—…ç†å­¦åŸºç¡€æ¨¡åž‹ä¸»è¦ä¾èµ–äºŽç»„ç»‡ç—…ç†å­¦å›¾åƒï¼Œå¿½ç•¥äº†åŸºå› ç»„å­¦ã€è¡¨è§‚åŸºå› ç»„å­¦å’Œè½¬å½•ç»„å­¦ç­‰å…¶ä»–é‡è¦çš„ç”Ÿç‰©å­¦ä¿¡æ¯ã€‚è¿™å¯¼è‡´æ¨¡åž‹æ— æ³•å…¨é¢ç†è§£è‚¿ç˜¤çš„å¤æ‚ç”Ÿç‰©å­¦æœºåˆ¶ï¼Œé™åˆ¶äº†å…¶åœ¨ç²¾å‡†è‚¿ç˜¤å­¦ä¸­çš„åº”ç”¨ã€‚çŽ°æœ‰æ–¹æ³•éš¾ä»¥æœ‰æ•ˆåœ°èžåˆè¿™äº›å¼‚æž„æ•°æ®ï¼Œå¹¶ä¿æŒç»„ç»‡ç—…ç†å­¦å›¾åƒçš„ç©ºé—´ç»“æž„ä¿¡æ¯ã€‚

**æ ¸å¿ƒæ€è·¯**ï¼šEXAONE Path 2.5çš„æ ¸å¿ƒæ€è·¯æ˜¯æž„å»ºä¸€ä¸ªå¤šæ¨¡æ€ç—…ç†å­¦åŸºç¡€æ¨¡åž‹ï¼Œè¯¥æ¨¡åž‹èƒ½å¤Ÿè”åˆå»ºæ¨¡ç»„ç»‡ç—…ç†å­¦å›¾åƒä»¥åŠåŸºå› ç»„å­¦ã€è¡¨è§‚åŸºå› ç»„å­¦å’Œè½¬å½•ç»„å­¦æ•°æ®ã€‚é€šè¿‡å¤šæ¨¡æ€å¯¹æ¯”å­¦ä¹ ï¼Œæ¨¡åž‹èƒ½å¤Ÿå­¦ä¹ åˆ°è·¨æ¨¡æ€çš„å…±äº«è¡¨å¾ï¼Œä»Žè€Œæ›´å…¨é¢åœ°ç†è§£è‚¿ç˜¤ç”Ÿç‰©å­¦ã€‚åŒæ—¶ï¼Œæ¨¡åž‹è¿˜ä¿ç•™äº†ç»„ç»‡ç—…ç†å­¦å›¾åƒçš„ç©ºé—´ç»“æž„ä¿¡æ¯ï¼Œè¿™å¯¹äºŽè‚¿ç˜¤çš„è¯Šæ–­å’Œé¢„åŽè‡³å…³é‡è¦ã€‚

**æŠ€æœ¯æ¡†æž¶**ï¼šEXAONE Path 2.5çš„æ•´ä½“æ¡†æž¶åŒ…æ‹¬ä»¥ä¸‹å‡ ä¸ªä¸»è¦æ¨¡å—ï¼š1) å¤šæ¨¡æ€æ•°æ®è¾“å…¥æ¨¡å—ï¼Œç”¨äºŽæŽ¥æ”¶ç»„ç»‡ç—…ç†å­¦å›¾åƒã€åŸºå› ç»„å­¦ã€è¡¨è§‚åŸºå› ç»„å­¦å’Œè½¬å½•ç»„å­¦æ•°æ®ï¼›2) é¢†åŸŸä¸“ç”¨åŸºç¡€æ¨¡åž‹æ¨¡å—ï¼ŒåŒ…æ‹¬WSIåŸºç¡€æ¨¡åž‹å’ŒRNA-seqåŸºç¡€æ¨¡åž‹ï¼Œç”¨äºŽæå–å„æ¨¡æ€çš„ç‰¹å¾ï¼›3) å¤šæ¨¡æ€å¯¹é½æ¨¡å—ï¼Œä½¿ç”¨å¤šæ¨¡æ€SigLIPæŸå¤±è¿›è¡Œè·¨æ¨¡æ€å¯¹æ¯”å­¦ä¹ ï¼Œå°†ä¸åŒæ¨¡æ€çš„ç‰¹å¾æ˜ å°„åˆ°åŒä¸€åµŒå…¥ç©ºé—´ï¼›4) ç‰‡æ®µæ„ŸçŸ¥æ—‹è½¬ä½ç½®ç¼–ç ï¼ˆF-RoPEï¼‰æ¨¡å—ï¼Œç”¨äºŽä¿ç•™WSIçš„ç©ºé—´ç»“æž„ä¿¡æ¯ï¼›5) é¢„æµ‹æ¨¡å—ï¼ŒåŸºäºŽå­¦ä¹ åˆ°çš„å¤šæ¨¡æ€è¡¨å¾è¿›è¡Œè‚¿ç˜¤è¯Šæ–­ã€é¢„åŽç­‰ä»»åŠ¡ã€‚

**å…³é”®åˆ›æ–°**ï¼šEXAONE Path 2.5çš„å…³é”®åˆ›æ–°ç‚¹åœ¨äºŽï¼š1) æå‡ºäº†å¤šæ¨¡æ€SigLIPæŸå¤±ï¼Œèƒ½å¤Ÿæœ‰æ•ˆåœ°è¿›è¡Œè·¨æ¨¡æ€å¯¹æ¯”å­¦ä¹ ï¼Œå­¦ä¹ åˆ°è·¨æ¨¡æ€çš„å…±äº«è¡¨å¾ï¼›2) æå‡ºäº†ç‰‡æ®µæ„ŸçŸ¥æ—‹è½¬ä½ç½®ç¼–ç ï¼ˆF-RoPEï¼‰æ¨¡å—ï¼Œèƒ½å¤Ÿä¿ç•™WSIçš„ç©ºé—´ç»“æž„ä¿¡æ¯ï¼Œè¿™å¯¹äºŽè‚¿ç˜¤çš„è¯Šæ–­å’Œé¢„åŽè‡³å…³é‡è¦ï¼›3) ä½¿ç”¨é¢†åŸŸä¸“ç”¨åŸºç¡€æ¨¡åž‹ï¼Œèƒ½å¤Ÿæ›´å¥½åœ°æå–å„æ¨¡æ€çš„ç‰¹å¾ã€‚

**å…³é”®è®¾è®¡**ï¼šå¤šæ¨¡æ€SigLIPæŸå¤±é‡‡ç”¨æ‰€æœ‰æˆå¯¹çš„å¯¹æ¯”å­¦ä¹ ï¼Œé¼“åŠ±æ¥è‡ªåŒä¸€æ‚£è€…çš„ä¸åŒæ¨¡æ€çš„åµŒå…¥å½¼æ­¤é è¿‘ï¼Œè€Œæ¥è‡ªä¸åŒæ‚£è€…çš„åµŒå…¥å½¼æ­¤è¿œç¦»ã€‚F-RoPEæ¨¡å—é€šè¿‡å°†WSIåˆ†å‰²æˆå¤šä¸ªç‰‡æ®µï¼Œå¹¶å¯¹æ¯ä¸ªç‰‡æ®µåº”ç”¨æ—‹è½¬ä½ç½®ç¼–ç ï¼Œä»Žè€Œä¿ç•™äº†WSIçš„ç©ºé—´ç»“æž„ä¿¡æ¯ã€‚WSIåŸºç¡€æ¨¡åž‹å’ŒRNA-seqåŸºç¡€æ¨¡åž‹é‡‡ç”¨é¢†åŸŸä¸“ç”¨çš„æž¶æž„å’Œé¢„è®­ç»ƒç­–ç•¥ï¼Œä»¥æ›´å¥½åœ°æå–å„æ¨¡æ€çš„ç‰¹å¾ã€‚

## ðŸ“Š å®žéªŒäº®ç‚¹

EXAONE Path 2.5åœ¨Patho-BenchåŸºå‡†æµ‹è¯•ä¸­å–å¾—äº†ä¸Žæœ€å…ˆè¿›çš„åŸºç¡€æ¨¡åž‹ç›¸å½“çš„æ€§èƒ½ï¼ŒåŒæ—¶åœ¨å†…éƒ¨ä¸´åºŠæ•°æ®é›†ä¸­è¡¨çŽ°å‡ºæ›´é«˜çš„é€‚åº”æ€§ã€‚è¿™è¡¨æ˜Žè¯¥æ¨¡åž‹å…·æœ‰è‰¯å¥½çš„æ³›åŒ–èƒ½åŠ›å’Œä¸´åºŠåº”ç”¨æ½œåŠ›ã€‚è¯¥æ¨¡åž‹åœ¨æ•°æ®å’Œå‚æ•°æ•ˆçŽ‡æ–¹é¢è¡¨çŽ°å‡ºè‰²ï¼Œèƒ½å¤Ÿåœ¨æœ‰é™çš„æ•°æ®å’Œè®¡ç®—èµ„æºä¸‹å–å¾—è‰¯å¥½çš„æ€§èƒ½ã€‚

## ðŸŽ¯ åº”ç”¨åœºæ™¯

EXAONE Path 2.5å¯åº”ç”¨äºŽç²¾å‡†è‚¿ç˜¤å­¦é¢†åŸŸï¼Œä¾‹å¦‚è‚¿ç˜¤è¯Šæ–­ã€é¢„åŽé¢„æµ‹ã€æ²»ç–—æ–¹æ¡ˆé€‰æ‹©ç­‰ã€‚é€šè¿‡æ•´åˆå¤šç»„å­¦æ•°æ®ï¼Œè¯¥æ¨¡åž‹èƒ½å¤Ÿæ›´å…¨é¢åœ°ç†è§£è‚¿ç˜¤ç”Ÿç‰©å­¦ï¼Œä»Žè€Œä¸ºä¸´åºŠåŒ»ç”Ÿæä¾›æ›´å‡†ç¡®çš„å†³ç­–æ”¯æŒã€‚è¯¥ç ”ç©¶ä¸ºä¸‹ä¸€ä»£ç²¾å‡†è‚¿ç˜¤å­¦å¥ å®šäº†åŸºç¡€ï¼Œæœ‰æœ›æ”¹å–„ç™Œç—‡æ‚£è€…çš„æ²»ç–—æ•ˆæžœã€‚

## ðŸ“„ æ‘˜è¦ï¼ˆåŽŸæ–‡ï¼‰

> Cancer progression arises from interactions across multiple biological layers, especially beyond morphological and across molecular layers that remain invisible to image-only models. To capture this broader biological landscape, we present EXAONE Path 2.5, a pathology foundation model that jointly models histologic, genomic, epigenetic and transcriptomic modalities, producing an integrated patient representation that reflects tumor biology more comprehensively. Our approach incorporates three key components: (1) multimodal SigLIP loss enabling all-pairwise contrastive learning across heterogeneous modalities, (2) a fragment-aware rotary positional encoding (F-RoPE) module that preserves spatial structure and tissue-fragment topology in WSI, and (3) domain-specialized internal foundation models for both WSI and RNA-seq to provide biologically grounded embeddings for robust multimodal alignment. We evaluate EXAONE Path 2.5 against six leading pathology foundation models across two complementary benchmarks: an internal real-world clinical dataset and the Patho-Bench benchmark covering 80 tasks. Our framework demonstrates high data and parameter efficiency, achieving on-par performance with state-of-the-art foundation models on Patho-Bench while exhibiting the highest adaptability in the internal clinical setting. These results highlight the value of biologically informed multimodal design and underscore the potential of integrated genotype-to-phenotype modeling for next-generation precision oncology.

